A meta-analysis of transfemoral versus transapical transcatheter aortic valve implantation on 30-day and 1-year outcomes

Heart Surgery Forum

Volumn 18, Issue 4, 2015, Pages E161-E166

  Zhao, An ^a   Minhui, Hu ^b   Li, Xu ^a   Zhiyun, Xu ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AORTA STENOSIS; ARTICLE; CEREBROVASCULAR ACCIDENT; EUROSCORE; HAZARD RATIO; HEART INFARCTION; HUMAN; MEDLINE; META ANALYSIS; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; RISK ASSESSMENT; SURGICAL APPROACH; SURVIVAL RATE; SYSTEMATIC REVIEW; TRANSCATHETER AORTIC VALVE IMPLANTATION; TREATMENT OUTCOME; VASCULAR DISEASE; WEB OF SCIENCE; AORTIC VALVE STENOSIS; CHINA; COMORBIDITY; EPIDEMIOLOGY; FEMALE; LONGITUDINAL STUDY; MALE; POSTOPERATIVE COMPLICATION; PREVALENCE; PROCEDURES; STATISTICS AND NUMERICAL DATA;

AORTIC VALVE STENOSIS; CHINA; COMORBIDITY; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; POSTOPERATIVE COMPLICATIONS; PREVALENCE; RISK ASSESSMENT; SURVIVAL RATE; TRANSCATHETER AORTIC VALVE REPLACEMENT; TREATMENT OUTCOME;

EID: 84941033488     PISSN: 10983511     EISSN: 15226662     Source Type: Journal    
DOI: 10.1532/hsf.1388     Document Type: Article

References (25)

1. Borz B, Durand E, Godin M, et al. 2013. Incidence, predictors and impact of bleeding after transcatheter aortic valve implantation using the balloon-expandable Edwards prosthesis. Heart 99:860-5.
2. Cribier A, Eltchaninoff H, Bash A, et al. 2002. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation 106:3006-8.
3. Dworakowski R, MacCarthy PA, Monaghan M, et al. 2010. Transcatheter aortic valve implantation for severe aortic stenosis-a new paradigm for multidisciplinary intervention. Am Heart J 160:237-43.
4. Ewe SH, Delgado V, Ng AC, et al. 2011. Outcomes after transcatheter aortic valve implantation: transfemoral versus transapical approach. Ann Thorac Surg 92:1244-51.
5. Gilard M, Eltchaninoff H, Iung B, et al. 2012. Registry of transcatheter aortic-valve implantation in high-risk patients. New England J Med 366:1705-15.
6. Giordana F, D'Ascenzo F, Nijhoff F, et al. 2014. Meta-analysis of predictors of all-cause mortality after transcatheter aortic valve implantation. Am J Cardiol 114:1447-55.
7. Griese DP, Reents W, Kerber S, et al. 2013. Emergency cardiac surgery during transfemoral and transapical transcatheter aortic valve implantation: incidence, reasons, management, and outcome of 411 patients from a single center. Cath Cardiovasc Intervent 82:E726-33.
8. Hemmann K, Sirotina M, De Rosa S, et al. 2013. The STS score is the strongest predictor of long-term survival following transcatheter aortic valve implantation, whereas access route (transapical versus transfemoral) has no predictive value beyond the periprocedural phase. Interact Cardiovasc Thorac Surg 17:359-64.
9. Himbert D, Descoutures F, Al-Attar N, et al. 2009. Results of transfemoral or transapical aortic valve implantation following a uniform assessment in high-risk patients with aortic stenosis. J Am Coll Cardiol 54:303-11.
10. Johansson M, Nozohoor S, Kimblad PO, et al. 2011. Transapical versus transfemoral aortic valve implantation: a comparison of survival and safety. Ann Thorac Surg 91:57-63.
11. Lefevre T, Kappetein AP, Wolner E, et al. 2011. One year follow-up of the multi-centre European PARTNER transcatheter heart valve study. Eur Heart J 32:148-57.
12. Li X, Kong M, Jiang D, et al. 2013. Comparison 30-day clinical complications between transfemoral versus transapical aortic valve replacement for aortic stenosis: a meta-analysis review. J Cardiothorac Surg 8:168.
13. Lotfi S, Dohmen G, Gotzenich A, et al. 2014. Midterm outcomes after transcatheter aortic valve implantation. Innovations (Philadelphia, Pa). 9:343-8.
14. Masson JB, Kovac J, Schuler G, et al. 2009. Transcatheter aortic valve implantation: review of the nature, management, and avoidance of procedural complications. JACC Cardiovasc Intervent 2:811-20.
15. Moher D, Liberati A, Tetzlaff J, et al. 2009. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ (Clinical research ed) 339:b2535.
16. Puls M, Viel T, Danner BC, et al. 2012. The risk-to-benefit ratio of transcatheter aortic valve implantation in specific patient cohorts: a single-centre experience. Clin Research Cardiol 101:553-63.
17. Rodes-Cabau J, Webb JG, Cheung A, et al. 2010. Transcatheter aortic valve implantation for the treatment of severe symptomatic aortic stenosis in patients at very high or prohibitive surgical risk: acute and late outcomes of the multicenter Canadian experience. J Am Coll Cardiol 55:1080-90.
18. Schymik G, Schrofel H, Schymik JS, et al. 2012. Acute and late outcomes of Transcatheter Aortic Valve Implantation (TAVI) for the treatment of severe symptomatic aortic stenosis in patients at high- and low-surgical risk. J Intervent Cardiol 25:364-74.
19. Stroup DF, Berlin JA, Morton SC, et al. 2000. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 283:2008-12.
20. Takagi H, Niwa M, Mizuno Y, et al. 2013. A meta-analysis of transcatheter aortic valve implantation versus surgical aortic valve replacement. Ann Thorac Surg 96:513-9.
21. Tierney JF, Stewart LA, Ghersi D, et al. 2007. Practical methods for incorporating summary time-to-event data into meta-analysis. Trials 8:16.
22. van der Boon RM, Marcheix B, Tchetche D, et al. 2014. Transapical versus transfemoral aortic valve implantation: a multicenter collaborative study. Ann Thorac Surg 97:22-8.
23. Van Mieghem NM, Chieffo A, Dumonteil N, et al. 2013. Trends in outcome after transfemoral transcatheter aortic valve implantation. Am Heart J 165:183-92.
24. Walters DL, Sinhal A, Baron D, et al. 2014. Initial experience with the balloon expandable Edwards-SAPIEN Transcatheter Heart Valve in Australia and New Zealand: the SOURCE ANZ registry: outcomes at 30 days and one year. Internat J Cardiol 170:406-12.
25. Webb JG, Altwegg L, Boone RH, et al. 2009. Transcatheter aortic valve implantation: impact on clinical and valve-related outcomes. Circulation 119:3009-16.